- Home
- FHN vs PCVX Comparison
FHN vs PCVX Comparison
Compare FHN & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHN
- PCVX
- Stock Information
- Founded
- FHN 1864
- PCVX 2013
- Country
- FHN United States
- PCVX United States
- Employees
- FHN N/A
- PCVX N/A
- Industry
- FHN Major Banks
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- FHN Finance
- PCVX Health Care
- Exchange
- FHN Nasdaq
- PCVX Nasdaq
- Market Cap
- FHN 10.7B
- PCVX 4.4B
- IPO Year
- FHN N/A
- PCVX 2020
- Fundamental
- Price
- FHN $21.92
- PCVX $35.76
- Analyst Decision
- FHN Buy
- PCVX Strong Buy
- Analyst Count
- FHN 17
- PCVX 10
- Target Price
- FHN $23.09
- PCVX $136.50
- AVG Volume (30 Days)
- FHN 5.9M
- PCVX 1.5M
- Earning Date
- FHN 07-16-2025
- PCVX 08-05-2025
- Dividend Yield
- FHN 2.74%
- PCVX N/A
- EPS Growth
- FHN N/A
- PCVX N/A
- EPS
- FHN 1.44
- PCVX N/A
- Revenue
- FHN $3,043,000,000.00
- PCVX N/A
- Revenue This Year
- FHN $11.18
- PCVX N/A
- Revenue Next Year
- FHN $3.73
- PCVX N/A
- P/E Ratio
- FHN $15.23
- PCVX N/A
- Revenue Growth
- FHN 3.43
- PCVX N/A
- 52 Week Low
- FHN $14.34
- PCVX $27.66
- 52 Week High
- FHN $22.44
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- FHN 68.56
- PCVX 57.77
- Support Level
- FHN $21.67
- PCVX $31.79
- Resistance Level
- FHN $22.22
- PCVX $36.89
- Average True Range (ATR)
- FHN 0.39
- PCVX 1.51
- MACD
- FHN 0.09
- PCVX 0.37
- Stochastic Oscillator
- FHN 87.94
- PCVX 77.65
About FHN First Horizon Corporation
First Horizon Corp is the parent company of First Tennessee Bank, a prominent regional bank with about 200 branches around Tennessee. The company's reportable segments are: Commercial, Consumer & Wealth, Wholesale, and Corporate. The majority of its revenue is generated from Commercial, Consumer & Wealth. The Commercial, Consumer & Wealth segment offers financial products and services, including traditional lending and deposit taking, to commercial and consumer clients in the southern USA and other selected markets.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.